Research led by BRC-funded Professor Lucy Wedderburn has shown that muscle pathology and myositis-specific antibodies (MSA) predict the risk of remaining on treatment in Juvenile Dermatomyositis (JDM). These findings could aid risk stratification.
The UK National Screening Committee, based on a research programme led by BRC-funded Professor Lynn Chitty, has recommended to the Government that NIPT for Down’s Syndrome be implemented into the NHS maternity care pathway and is currently awaiting minist
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be m
SCIDNET is a European Commission Horizon 2020 -funded project which launched in January 2016. It aims to take gene therapy from current clinical trials to a medicinal product that can be delivered to any child in the EU. It follows on from previous EU col
Research led by BRC funded Professor Kathy Pritchard-Jones has demonstrated the importance of prognostic biomarkers in improving risk stratification in Wilms’ Tumour (WT).